GlassScriptPhysician profile
Muriel K Boreham
NPI 1346273034
$12,201.27
in general payments reported to CMS, 2019-2025
27 companies · $4,281 in 2025
The $4,281 reported for 2025 was more than what 91% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $218 · 2021: $1,047 · 2022: $533 · 2023: $5,064 · 2024: $548 · 2025: $4,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,250 · Food and Beverage: $1,543 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,250.00 |
| Food and Beverage | $1,542.89 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $8,250.00 | 2023-2025 | Zoryve |
| Astellas Pharma US INC | $789.28 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $641.42 | 2023-2025 | Gemtesa |
| Abbvie INC. | $480.74 | 2022-2025 | Botox |
| Allergan, INC. | $383.11 | 2019-2022 | |
| Axonics, INC. | $338.79 | 2020-2024 | Axonics |
| Caldera Medical, INC | $210.70 | 2021-2025 | Desara |
| Convatec INC. | $195.77 | 2023-2024 | |
| Urovant Sciences INC | $135.55 | 2021-2022 | |
| Therapeuticsmd, INC. | $135.18 | 2019-2022 | |
| Millicent US INC | $121.90 | 2021-2023 | Intrarosa |
| Intuitive Surgical, INC. | $89.51 | 2024 | |
| Mission Pharmacal Company | $62.37 | 2019-2024 | Uribel Tabs |
| Medtronic, INC. | $50.26 | 2021-2025 | Interstim |
| Avation Medical, INC. | $49.20 | 2025 | Vivally System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $40.99 | 2024-2025 | |
| Medtronic USA, INC. | $40.54 | 2019-2020 | |
| Ethicon US, LLC | $32.78 | 2021 | |
| Duchesnay USA Incorporated | $26.28 | 2019 | |
| Rochester Medical Corporation | $21.77 | 2022 | |
| Zyla Life Sciences, INC. | $21.14 | 2019 | |
| Bluewind Medical | $17.31 | 2025 | Revi |
| Amag Pharmaceuticals, INC. | $15.98 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.58 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.38 | 2019 | |
| 180 Medical, INC. | $14.09 | 2019 | |
| Boston Scientific Corporation | $5.65 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muriel Boreham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.